Long-Term Treatment Patterns of Biologics and Apremilast Among Patients with Moderate-to-Severe Plaque Psoriasis by Psoriatic Arthritis Status

被引：0

作者：

Feldman, Steven ^{[1
]}

Zhang, Jingchuan ^{[2
]}

Martinez, Diane ^{[3
]}

Lopez-Gonzalez, Lorena ^{[3
]}

Marchlewicz, Elizabeth Holt ^{[3
]}

Shrady, George ^{[3
]}

Mendelsohn, Alan ^{[2
]}

Zhao, Yang ^{[2
]}

机构：

[1] Wake Forest Baptist Hlth, Winston Salem, NC USA

[2] Sun Pharmaceut Ind, Princeton, NJ USA

[3] IBM Watson Hlth, Washington, DC USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1520

引用

页数：2

共 50 条

[21] TREATMENT SATISFACTION AMONG PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS IN BRAZIL [J].

Lopes, N. ;

Suarez, R. M. ;

Sabbag, C. Y. ;

Kobata, C. M. ;

Takemoto, M. S. ;

Pertel, P. .

VALUE IN HEALTH, 2017, 20 (09) :A902-A902

[22] Apremilast in moderate-to-severe plaque psoriasis (ESTEEM 2 trial) [J].

Anstey, Alex .

BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (06) :E23-E23

[23] Combination therapy of apremilast and secukinumab in patients with moderate-to-severe, recalcitrant plaque psoriasis [J].

Sacchelli, L. ;

Patrizi, A. ;

Loi, C. ;

Bardazzi, F. .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (07) :E243-E244

[24] SECUKINUMAB DEMONSTRATES CONSISTENT SAFETY OVER LONG-TERM EXPOSURE IN PATIENTS WITH PSORIATIC ARTHRITIS AND MODERATE-TO-SEVERE PLAQUE PSORIASIS: UPDATED POOLED SAFETY ANALYSES [J].

Mease, P. J. ;

McInnes, I. B. ;

Reich, K. ;

Nash, P. ;

Andersson, M. ;

Abrams, K. ;

Pricorp, L. ;

Fox, T. .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 :683-683

[25] SECUKINUMAB DEMONSTRATES CONSISTENT SAFETY OVER LONG-TERM EXPOSURE IN PATIENTS WITH PSORIATIC ARTHRITIS AND MODERATE-TO-SEVERE PLAQUE PSORIASIS: UPDATED POOLED SAFETY ANALYSES [J].

McInnes, Lain ;

Mease, Philip ;

Reich, Kristian ;

Nash, Peter ;

Andersson, Mats ;

Abrams, Ken ;

Pricop, Luminita ;

Fox, Todd .

RHEUMATOLOGY, 2018, 57

[26] BUDGET IMPACT ANALYSIS OF APREMILAST IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS IN GREECE [J].

Solakidi, A. ;

Tzanetakos, C. ;

Kourlaba, G. ;

Maniadakis, N. .

VALUE IN HEALTH, 2018, 21 :S424-S425

[27] Treatment of moderate-to-severe plaque psoriasis [J].

Salgo, R. ;

Thaci, D. .

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (06) :701-711

[28] Economic and Comorbidity Burden Among Moderate-to-Severe Psoriasis Patients Comorbid with Psoriatic Arthritis [J].

Feldman, Steven R. ;

Zhao, Yang ;

Shi, Lizheng ;

Lu, Jackie ;

Tran, MaryHelen .

ARTHRITIS & RHEUMATOLOGY, 2014, 66 :S680-S681

[29] Economic and Comorbidity Burden Among Moderate-to-Severe Psoriasis Patients With Comorbid Psoriatic Arthritis [J].

Feldman, Steven R. ;

Zhao, Yang ;

Shi, Lizheng ;

Mary Helen Tran ;

Lu, Jackie .

ARTHRITIS CARE & RESEARCH, 2015, 67 (05) :708-717

[30] Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics [J].

Sator, P. ;

Richter, L. ;

Saxinger, W. ;

Vasiljevic, M. ;

Stingl, G. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (09) :1742-1749

← 1 2 3 4 5 →